SCHEMBL4073004

SCHEMBL4073004

Cc1cccc(N2CC[CH]CC2)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.65
KCNH2 Q12809 3/20 0.57
MAPT P10636 3/20 0.53
ALDH1A1 P00352 1/20 0.53
RAB9A P51151 1/20 0.53
DHFR P00374 2/20 0.48
NOTUM Q6P988 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
HTR7 P34969 1/20 0.47
C1S P09871 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
ALOX5 P09917 1/20 0.45
HSP90AA1 P07900 1/20 0.44
MGLL Q99685 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069199 0.89 ADRB1 (0.56) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL11103700 0.87 ADRB1 (0.74) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL10373770 0.87 ADRB1 (0.74) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL8264176 0.83 ADRB1 (0.69) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL12991 0.83 ADRB1 (0.69) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL3307690 0.82 ADRB1 (0.67) ADRB1KCNH2MAPTALDH1A1RAB9A
Hydrochloric Acid SCHEMBL27827352 0.82 ADRB1 (0.67) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL17281442 0.82 ADRB1 (0.67) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL11096302 0.82 KCNH2 (0.73) ADRB1KCNH2MAPTALDH1A1RAB9A
SCHEMBL8263647 0.81 ADRB1 (0.56) ADRB1KCNH2MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102947275-A Piperidinyl-substituted 1, 3-dihydro-benzimidazol-2-ylideneamine derivatives NOVARTIS AG 2013-02-27 CN disclosed
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
EP-1836180-A2 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS sanofi-aventis (FR) 2007-09-26 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed
WO-2006072393-A2 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI-AVENTIS (DE) 2006-07-13 WO disclosed